Ba Ge said: "I understand. is like Wu Fanfan, who participated in that rap show and brought a lot of traffic outside the circle into the circle. Although many people spray him for not being able to rap, and even look down on him, this show can be so popular, and the art form of rap can get out of the circle, he has made indelible contributions, although many of the original 'insiders' don't care about this. ”

After speaking, Ba Reyou glanced at Han Zhou and said in a low voice: "Although this is the truth, I still don't want to be scolded." You know, there will definitely be netizens who scold me for not knowing how to be a judge. ”

Han Zhou said: "It's okay, you are a judge outside the circle, there will be a judge in the circle to partner with you, she is responsible for professional reviews, and you are responsible for being beautiful like a flower." ”

Bage chuckled.

......

A busy day.

Early the next morning, Han Zhou received a WeChat message from Wang Shenghai.

Wang Shenghai: Mr. Han, under your leadership, with the concern of the country, and with the joint efforts of our company and various cooperative universities, the anti-cancer drug "Baoxiangsu" has been officially put into production. The first phase of the factory was built on the outskirts of Beijing, and currently has only one assembly line, which can produce about 500 copies (each of which can cure a patient) "Baoxiangxin" per day.

Happy Little Leapfrog: Yes, you're very efficient. What I don't know much about, though, is how far we need to increase our capacity to meet domestic demand?

Wang Shenghai: Mr. Han, I have a report on this issue here, you can take a look at it.

Wang Shenghai: [Document] National Cancer Center Releases: 2019 National Cancer Report!

Han Zhou clicked on it.

The more I watched, the more frightened I became.

(Since the data of the National Cancer Registry Center is generally delayed by 3 years, the data released in this report is the National Cancer Registry Center to collect and summarize the registration data of the National Cancer Registry in 2015.) ）

In 2015, there were about 3.929 million cases of malignant tumors and about 2.338 million deaths.

On average, more than 10,000 people are diagnosed with cancer every day, and 7.5 people are diagnosed with cancer every minute.

Compared to historical data, the cancer burden continues to rise. In the past 10 years, the incidence of malignant tumors has maintained an annual increase of about 3.9%, and the mortality rate has maintained an annual increase of 2.5%.

In 2015, the incidence, mortality and cancer spectrum of malignant tumors in China were basically the same as those in 2014, and the standardized incidence level was basically the same, while the number of cases increased, indicating that the current increase in cancer burden is mainly due to the aging of the population structure.

As people get older, they are more likely to get cancer. Although the average life expectancy in China is getting higher and higher, there are still very few people who can live to the end of their natural life expectancy, that is, the so-called "end of life". Many elderly people have been killed by various diseases. Cancer and cardiovascular disease are the major contributors.

Judging by the type of cancer.

Lung cancer, liver cancer, upper gastrointestinal system tumors, colorectal cancer, and female breast cancer are still the main malignant tumors in China.

Lung cancer is the number one cancer in men and is directly related to smoking. Liver cancer is associated with hepatitis B and liver flukes (Shunde Yusheng).

Breast cancer is the most common occurrence in women.

Prostate cancer in men has been on the rise in recent years, ranking sixth among men. The prostate gland should still be protected.

The number of new cases in urban areas is about 2.352 million, accounting for 59.86% of the new cases in the country. The number of new cases in rural areas is about 1.577 million, accounting for 40.14% of the new cases in the country. The top 10 malignant tumor deaths in urban and rural areas accounted for 81.30% and 85.20% of all malignant tumor deaths in urban and rural areas, respectively.

This may also be related to the poor medical conditions in rural areas, the narrow coverage of physical examinations, and the fact that many rural people suffer from cancer but do not know it until it worsens, and it is not diagnosed until it is in the middle or late stages.

The report concludes that malignant tumors are a major category of diseases that seriously threaten the health of Chinese residents. With the gradual aging of China's population, the acceleration of industrialization and urbanization, and the accumulation of risk factors such as chronic infection, unhealthy lifestyle, and environment, the prevention and control situation is grim.

Han Zhou thought about it and typed back to Wang Shenghai.

Happy Little Leapfrog: There are more than 10,000 confirmed cases a day in my country, and now a production line can only produce 500 copies per day, so it needs to be at least 20 times more to barely meet the demand.

Happy Little Jumping Frog: And that's just the increment. If we look at the stock, there are still millions of diagnosed cancer patients in China, and there is an urgent need for "Baoxiangxin" to save lives. Some of them have terminal cancer, and they are in a race against death.

Happy Little Jumping Frog: I ask two questions.

Wang Shenghai: Mr. Han, you ask.

Happy Little Leapfrog: As I said before, we will give priority to the supply of "Baoxiangxin" to soldiers, teachers and national scientific researchers with terminal cancer.

Wang Shenghai: It has been being done, but the supply exceeds the demand. Among them, teachers and scientific researchers are purchased within a few hundred yuan according to the price of medical insurance, and the vast majority of teachers and scientific researchers can easily afford this price. For the few who can't afford it, we have directly given them relief to ensure that everyone can see a doctor and survive.

Wang Shenghai: Military personnel and retired soldiers are directly reimbursed by the state.

Happy Little Jumping Frog: Well, next, our products will be given priority to military personnel, teachers, national scientific researchers, and their families. Including the relatives of martyrs, etc.

Wang Shenghai: Okay, I will definitely do this.

Happy Little Jumping Frog: The second thing is, can the production capacity of Baoxiangxen be increased quickly, and to what extent?

Wang Shenghai: At present, this factory in Beijing can quickly add about 10 more production lines, which is equivalent to increasing the production capacity to "produce 5,500 copies of Baopixel per day". It takes time to ramp up the production capacity, there is no way, there are too few professionals, and it is expected to be gradually built within half a year.

Wang Shenghai: At the same time, we are also bidding for factories in other places as soon as possible. Strive to build more than 5 within a year, and the national production capacity will reach "20,000 copies per day", which will basically meet the domestic stock and incremental demand, and at the same time sell an appropriate amount to foreign countries.

Happy Little Jumping Frog: Yes.

Happy Little Jumping Frog: This human tragedy will be completely ended by us.

Wang Shenghai: Mr. Han. The state hopes that our company will hold a "global conference on anti-cancer drugs" to announce this good news to the whole country and the world, and give hope to cancer patients.

Happy Little Jumping Frog: Yes, let's prepare now, and we'll all be there then.

Wang Shenghai: Mr. Han, you are the soul of the research and development of "Baoxiangxin", at the press conference, you will make a speech on behalf of all of us. This can only be done by you, and no one else is qualified, including me.

Happy Little Jumping Frog: Okay.

......

A week later.

"Global launch of the anti-cancer drug 'Baoxiangxin'".

In the capital, the Bird's Nest, officially held.